written on 16.06.2014

Dealing with Human Error in Life Sciences


We recently came across an interesting case that raised the question of how we should deal with human error in life sciences. This unprecedented legal case, ”…the first in which a structural reassignment puts in jeopardy a patent and clinical trials…” can be found here. The story: Oncoceutics announced that their proprietary drug ONC-201 (also […]